Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | INEBILIZUMAB (Uplizna) | [1] Inebilizumab Inebilizumab (Uplizna) | [1] Inebilizumab
Inebilizumab
(Uplizna) 💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [4] 11 11, 13, 51, 300 💬
|
| 2 | Uplizna | [1] Inebilizumab Inebilizumab (Uplizna) | [1] Inebilizumab
Inebilizumab
(Uplizna) 💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [2] 11 11, 300 💬
|